Brenno Telles

With close to a decade of experience, Brenno’s practice concentrates on high stakes and high complexity regulatory and intellectual property matters, focusing on the pharmaceutical and biotechnology sectors. He collaborates closely with our the team of technical experts to provide clients with the best prosecution strategies to generate valuable and actionable portfolios. He also has extensive experience in assisting clients in enforcing and defending against attacks on their IP rights in Brazil.

Brenno was deeply involved in many of groundbreaking IP cases of the past decade. He was instrumental in the development and successful implementation of the strategies for the first contributory infringement, first infringement based on offer for sale, as well as the first patent enforcement lawsuit against infringing biosimilars in Brazil. He was also second-chair in the case that resulted in the first confirmed preemptive preliminary injunction ordering a biosimilar manufacturer to refrain from launching an infringing product even before its marketing authorization had been granted.

Education

J.D. from Universidade Federal Fluminense (UFF).

Publications

English

ANVISA approves skinny labeling in Brazil (Kluwer Patent Blog, 2023).

Brazilian government resurrects its Partnership for Productive Development (PDP) program. A new threat to pharma IP rights.

Brazil: The Patent Office is Considering Changing Terms for Requesting Examination and Amending Patent Applications (Kluwer Patent Blog, 2023).

The relevance of court-appointed examiners on patent cases in Brazil (Kluwer Patent Blog, 2023).

Patent Term Adjustment in Brazil at the centre of major battle for IP owners (IAM, 2023).

Brazil: leading case allows revival of a patent application (Kluwer Patent Blog, 2023).

Brazilian generic companies file a “tsunami” of lawsuits against several pharmaceutical companies in the wake of the Supreme Court’s ruling on the 10-year patent term (BRICS & Beyond, 2021).

New Requirements in Brazil for Plant Variety Protection Applications in View of Brazil’s Biodiversity Law (The National Law Review, 2016)

Portuguese

Governo relança PDPs, preocupação compropriedade intelectual na indústria farmacêutica (Decisor Brasil, 2023).

Languages

Portuguese
English